Vimarsana
Biggest News Aggregation in the World

Page 23 - Genome Editing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Genome Editing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Genome Editing Today - Breaking & Trending Today

Gene-editing reverses vision loss in mice - Vimarsana News

Gene-editing reverses vision loss in mice

Researchers used CRISPR-based genome editing to successfully restore vision in mice with retinitis pigmentosa, a major cause of blindness in humans.

Soft Tissue Repair Market to Surpass US$ 10,392.1 Million by 2030, Says Coherent Market Insights (CMI) - Vimarsana News

Soft Tissue Repair Market to Surpass US$ 10,392.1 Million by 2030, Says Coherent Market Insights (CMI)

According to Coherent Market Insights, the global soft tissue repair market is estimated to be valued at US$ 6,943.4 million in 2023 and is expected to exhibit

Federal Govt, AUDA-NEPAD Revolutionizing African Agriculture Through Genome-editing Tech - Vimarsana News

Federal Govt, AUDA-NEPAD Revolutionizing African Agriculture Through Genome-editing Tech

The Nigerian Federal Government and other countries in Africa have taken steps to revolutionize agriculture and boost the continent’s potential for industrial

Ethical concerns temper optimism about gene-editing for human diseases - Vimarsana News

Ethical concerns temper optimism about gene-editing for human diseases

The Third International Summit on Genome Editing concluded Monday with ethicists warning scientists to slow down efforts to use gene-editing to enhance the health of embryos.

Source: wshu.org
Gene editing benefits and risks debated at London meeting : Shots - Vimarsana News

Gene editing benefits and risks debated at London meeting : Shots

The Third International Summit on Genome Editing concluded Monday with ethicists warning scientists to slow down efforts to use gene-editing to enhance the health of embryos.

Source: npr.org